Literature DB >> 8855307

Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis.

A Itoh1, T Maki.   

Abstract

Nonobese diabetic mice spontaneously develop diabetes that is caused by autoimmune cell-mediated destruction of pancreatic beta cells. Here we report that surgical removal of 90% of pancreatic tissue before onset of insulitis induced a long-term diabetes-free condition in nonobese diabetic mice. Pancreatectomy after development of moderate insulitis had no effect on the course of diabetes. The effect of pancreatectomy was abrogated with subsequent development of diabetes by infusion of islet-cell-specific T lymphocytes and by transplantation of pancreatic islets. Lymphocytes from pancreatectomized diabetes-free mice exhibited low response to islet cells but responded normally to alloantigens. These results suggest that the islet cell mass plays a critical role in development of autoimmune diabetes.

Entities:  

Mesh:

Year:  1996        PMID: 8855307      PMCID: PMC38282          DOI: 10.1073/pnas.93.20.11053

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  The pathogenesis of insulin-dependent diabetes mellitus.

Authors:  M A Atkinson; N K Maclaren
Journal:  N Engl J Med       Date:  1994-11-24       Impact factor: 91.245

Review 2.  Insulin-dependent diabetes mellitus: the initial lesion.

Authors:  G F Cahill; H O McDevitt
Journal:  N Engl J Med       Date:  1981-06-11       Impact factor: 91.245

3.  Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent.

Authors:  Y Wang; L Hao; R G Gill; K J Lafferty
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

4.  The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue.

Authors:  A K Foulis; J A Stewart
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

5.  Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus.

Authors:  A N Gorsuch; K M Spencer; J Lister; J M McNally; B M Dean; G F Bottazzo; A G Cudworth
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

6.  Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.

Authors:  L S Wicker; B J Miller; Y Mullen
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

7.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

8.  Insulin antibodies in insulin-dependent diabetics before insulin treatment.

Authors:  J P Palmer; C M Asplin; P Clemons; K Lyen; O Tatpati; P K Raghu; T L Paquette
Journal:  Science       Date:  1983-12-23       Impact factor: 47.728

9.  Breeding of a non-obese, diabetic strain of mice.

Authors:  S Makino; K Kunimoto; Y Muraoka; Y Mizushima; K Katagiri; Y Tochino
Journal:  Jikken Dobutsu       Date:  1980-01

10.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

Authors:  A Bendelac; C Carnaud; C Boitard; J F Bach
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Temporal discontinuities in progression of NOD autoimmune diabetes.

Authors:  G B Rudy; R M Sutherland; A M Lew
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

2.  Tet2 Controls the Responses of β cells to Inflammation in Autoimmune Diabetes.

Authors:  Jinxiu Rui; Songyan Deng; Ana Luisa Perdigoto; Gerald Ponath; Romy Kursawe; Nathan Lawlor; Tomokazu Sumida; Maya Levine-Ritterman; Michael L Stitzel; David Pitt; Jun Lu; Kevan C Herold
Journal:  Nat Commun       Date:  2021-08-20       Impact factor: 14.919

3.  Exendin-4 modulates diabetes onset in nonobese diabetic mice.

Authors:  Irene Hadjiyanni; Laurie L Baggio; Philippe Poussier; Daniel J Drucker
Journal:  Endocrinology       Date:  2007-12-06       Impact factor: 4.736

4.  Beta cell MHC class I is a late requirement for diabetes.

Authors:  Emma E Hamilton-Williams; Stephanie E Palmer; Brett Charlton; Robyn M Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-15       Impact factor: 11.205

Review 5.  Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation.

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

6.  Therapeutic approach for type 1 diabetes mellitus using the novel immunomodulator FTY720 (fingolimod) in combination with once-daily injection of insulin glargine in non-obese diabetic mice.

Authors:  Takumi Tsuji; Mariko Inoue; Yuya Yoshida; Tetsuro Fujita; Yukikazu Kaino; Takeyuki Kohno
Journal:  J Diabetes Investig       Date:  2012-03-28       Impact factor: 4.232

7.  Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase-4 inhibitor, examined in non-obese diabetic mice.

Authors:  Takumi Tsuji; Yuya Yoshida; Tetsuro Fujita; Takeyuki Kohno
Journal:  J Diabetes Investig       Date:  2012-10-18       Impact factor: 4.232

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.